Navigation Links
OGI's investment in cytognomix contributes to the Shannon Human Splicing Pipeline's success
Date:4/29/2013

TORONTO, ON, April 29, 2013 - Ontario Genomics Institute (OGI) congratulates Cytognomix on the success of the Shannon Human Splicing Pipeline, which was recently purchased by the National Cancer Institute (NCI) in the U.S. In 2009, OGI invested in Cytognomix through its Pre-commercialization Business Development Fund (PBDF).

Understanding the wealth of data generated by next-generation sequencing is essential to determining which mutations are clinically significant. Cytognomix's Shannon pipeline assesses the millions of variants of unknown significance detected in cancer genetic testing by predicting mRNA splicing abnormalities. This technology improves accuracy and ease of data interpretation, saving time and reducing mistakes.

Investigators at NCI are using the Shannon pipeline to evaluate somatic and germline variants observed in tumor genome next generation sequences for their potential effects on splicing. According to Dr. Mike Nickerson, Cancer and Inflammation Program, NCI, the analytic tool is being applied to evaluate a variety of variants which can be difficult to interpret in terms of their effects on protein function. Analysis of variants for potential effects on splicing provides a tool to distinguish deleterious mutations from passenger variants and generates hypotheses that can be experimentally evaluated using PCR of reverse-transcribed tumor RNA.

"Cytognomix's Shannon pipeline is resolving significant data interpretation issues in cancer research," said Mark Poznansky, CEO, OGI. "It is rewarding to see the companies we invest in succeed and grow. OGI's investment provided Cytognomix with early stage funding, which allowed them to take important next steps toward bringing their products to market."

According to Peter Rogan, CEO of Cytognomix, "Interpreting gene variants of unknown clinical significance is one of the most important challenges in human genomics. While much effort has been focused on gathering existing knowledge about published variants in databases, our Shannon pipeline discovers previously unrecognized functions of non-coding variants. Cytognomix's mutation analysis software products have been validated in numerous peer-reviewed journal publications. We are pleased that the NCI has chosen the Shannon mRNA splicing mutation pipeline to accelerate their understanding of various forms of cancer."

OGI's PBDF program has invested in opportunities based in genomics, proteomics or associated technologies that fall in the proof-of-principle (validation) phase of research and that have the short-term potential to secure a significant next step towards the marketplace. Previous recipients have included Ontario universities, research institutes and companies.


'/>"/>

Contact: Christine Beyaert
cbeyaert@ontariogenomics.ca
416-673-6597
Ontario Genomics Institute
Source:Eurekalert

Related biology news :

1. IU biologists offer clearer picture of how protein machine systems tweak gene expression
2. Microbiologists can now measure extremely slow life
3. American Society of Plant Biologists honors early career women scientists
4. Interventional radiologists see significant symptom relief in MS patients
5. In search for a vaccine, IU biologist receives $2.3 million to explore chlamydia genomics
6. Penn biologists identify a key enzyme involved in protecting nerves from degeneration
7. University of Toronto biologists predict extinction for organisms with poor quality genes
8. UC Riverside plant cell biologist receives top scientific honor
9. Biologists turn back the clock to understand evolution of sex differences
10. Radiologists study necessity of additional imaging recommendations in PET/CT oncologic reports
11. Anthropologist finds explanation for hominin brain evolution in famous fossil
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/4/2019)... ... April 03, 2019 , ... R3 Stem ... at its nationwide Centers of Excellence. R3 wants patients to feel secure when ... To protect patients from Centers that use inferior regenerative biologics, protocols or amounts, ...
(Date:3/29/2019)... ... March 28, 2019 , ... In the wake ... programme entirely dedicated to Chinese biobanks was launched in July 2018, in an ... the Biobank Branch, China Medicinal Biotech Association (BBCMBA). The one-year pilot programme offered ...
(Date:3/27/2019)... ... 2019 , ... Evan Holden , a shareholder in the Atlanta ... at the National Academy of Sciences (NAS) Roundtable on Biomedical Engineering Materials Applications (BEMA), ... firm’s award-winning Pharmaceutical, Medical Device & Health Care Litigation Practice , addressed, “Medical ...
Breaking Biology News(10 mins):
(Date:4/9/2019)... ... 09, 2019 , ... The American Society of Gene & Cell Therapy ... including a new addition to the presidential line of succession, at the 22nd ... Society's leadership team for a three-year term (2019-2021). , All five incoming members of ...
(Date:4/4/2019)... ... April 03, 2019 , ... LeadingBiotech, an exclusive ... dialogue, today announces its Boston CEO conference to be held May 28-29, 2019 ... and opportunities with high-level panels and discussions from past, present and future change-makers. ...
(Date:3/23/2019)... ... March 22, 2019 , ... uBiome has awarded microbiome ... of researchers at Nnamdi Azikiwe University in Anambra State, Nigeria led by Dr. ... the Department of Medical Laboratory Sciences and Deputy Provost, College of Health Sciences. ...
(Date:3/19/2019)... ... March 19, 2019 , ... Konica ... today announced the formation of their inaugural Scientific Advisory Board. , ... that takes into account individual variability in genes, environment, and lifestyle to more ...
Breaking Biology Technology: